Nutanix is thriving as it shifts towards software-only sales, with its software-defined hyper converged infrastructure solutions supporting multi-hypervisor and multi-cloud environments. The company’s built-in hypervisor, AHV, is gaining popularity as a cost-effective alternative for customers. In the last quarter, Nutanix saw a 13.7% year-over-year increase in software and support revenues, with AHV adoption rising by 47% over four quarters.
Nutanix has expanded its platform to include new features for Big Data and analytics applications, as well as unstructured data storage. These enhancements aim to improve performance, scalability, and cost-efficiency by integrating object storage services with Nutanix’s HCI solution.
The company’s software is known for its scalability, simplicity, and automation capabilities, reducing the need for data scientists and security teams to extract value from data. Nutanix holds a 13% market share in the HCI market and is well-positioned for long-term growth, according to IDC and Gartner. Its partnerships with Google and Dell further strengthen its market position.
Given the promising growth prospects of the HCI market, Nutanix is expected to continue benefiting from its portfolio strength and partnerships. The company currently holds a Zacks Rank #3 (Hold).
For investors looking to capitalize on the biotech sector’s potential, Zacks has identified 7 Biotech Stocks with Triple-Digit Profit Potential that could outperform the market. Nutanix’s recent achievements and partnerships position it well for future success in the HCI market.
Article Source
https://uk.movies.yahoo.com/movies/movies/nutanix-rides-solid-hci-portfolio-142902749.html
